Salient Capital Advisors’s ChampionX CHX Stock Holding History

Salient Capital Advisors’s Portfolio CHX Stock Details CHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-26,404	Closed	-$404K	–	68
2020 Q4	$404K	Sell	26,404 -46,997	-64%	-$522K	0.02%	69
2020 Q3	$586K	Buy	73,401 +3,676	+5%	+$35.4K	0.04%	54
2020 Q2	$681K	Buy	69,725 +55,259	+382%	+$506K	0.03%	44
2020 Q1	$83K	Buy	+14,466	New	+$301K	0.01%	56

Other funds holding CHX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Salient Capital Advisors's CHX Position: Q1 2021 in Review

Salient Capital Advisors sold out of ChampionX (CHX) in Q1 2021, closing a stake of 26,404 shares — an estimated $404K sold.

Salient Capital Advisors first reported a position in CHX in Q1 2020 and held it in 4 quarters. The position peaked at $681K in Q2 2020. 306 funds tracked by Wall St. Rank hold CHX as of Q1 2021.

Salient Capital Advisors reported no remaining ChampionX position as of Q1 2021 after selling out during the quarter.
Salient Capital Advisors sold 26,404 ChampionX shares in Q1 2021, an estimated $404K.
Salient Capital Advisors first reported a position in ChampionX in Q1 2020 and held it in 4 quarters.
Salient Capital Advisors's ChampionX position peaked at $681K in Q2 2020.
306 funds tracked by Wall St. Rank held ChampionX as of Q1 2021.

Based on Salient Capital Advisors's 13F filing for Q1 2021, filed 6 May 2021.